Amylyx Pharmaceuticals, Inc. SEC filings AMLX
Amylyx Pharmaceuticals, Inc. has 440 filings in SEC EDGAR's recent list, going back to Nov 17, 2015. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Mar 26, 2025 | — |
| CORRESP | Letter to the SEC | Mar 24, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 5, 2025 | — |
| POSASR | Filing | Mar 4, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2023 | — |
| CORRESP | Letter to the SEC | Dec 19, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 5, 2023 | — |
| EFFECT | Filing | Oct 6, 2022 | — |
| CORRESP | Letter to the SEC | Oct 4, 2022 | — |
| CORRESP | Letter to the SEC | Oct 4, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2022 | — |
| DRS | Filing | Aug 24, 2022 | — |
| SEC STAFF LETTER | Filing | Jan 6, 2022 | — |
| EFFECT | Filing | Jan 6, 2022 | — |
| CERT | Filing | Jan 6, 2022 | — |
| CORRESP | Letter to the SEC | Jan 4, 2022 | — |
| CORRESP | Letter to the SEC | Jan 4, 2022 | — |
| 8-A12B | Filing | Jan 4, 2022 | — |
| CORRESP | Letter to the SEC | Dec 16, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2021 | — |
| SEC STAFF LETTER | Filing | Dec 1, 2021 | — |
| DRS/A | Filing | Nov 26, 2021 | — |
| DRSLTR | Filing | Nov 24, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 23, 2021 | — |
| DRSLTR | Filing | Oct 20, 2021 | — |
| DRS/A | Filing | Oct 20, 2021 | — |
| UPLOAD | Letter from the SEC | May 28, 2021 | — |
| DRS | Filing | Apr 26, 2021 | — |
| D | Filing | Jul 1, 2020 | — |
| D/A | Filing | Jan 28, 2020 | — |
| D/A | Filing | Dec 31, 2019 | — |
| D | Filing | Dec 31, 2019 | — |
| D | Filing | Nov 20, 2018 | — |
| D | Filing | Aug 4, 2017 | — |
| D/A | Filing | Aug 22, 2016 | — |
| D | Filing | Aug 22, 2016 | — |
| D/A | Filing | Nov 20, 2015 | — |
| D | Filing | Nov 17, 2015 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AMLX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1658551
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.